SIGN UP
LOG IN
A
ATHE
Alterity Therapeutics Ltd
3.54
0.03+0.85%After Hours: 3.540 0.00 0.00%16:05 04/24 EDT
OPEN/PREV CLOSE3.410/3.510
TODAY RANGE3.410-3.540
VOL2.76K
MARKET CAP53.85M
52 WEEK RANGE1.001-5.87
AVG VOL (3M)450.25K
% TURNOVER0.02%
TURNOVER--
P/E (TTM)-2.3544
% RANGE3.70%
EPS(TTM)-1.5036
P/E(FORWARD)-4.3171
P/B6.49
BVPS0.5457
DIVIDEND--
P/S35,400.00
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP53.83M
SHARES OUTSTANDING15.21M
NEXT EARNINGS08/04-08/08
FREE FLOAT15.21M
LOT SIZE1
EX-DIV DATE01/09/2023
News
Press Releases
Financial Reports
Profile
TipRanks·04/10 11:45
Alterity Therapeutics reports new data from ATH434 Phase 2 trial at AAN meeting
TipRanks·03/27 11:30
Alterity Therapeutics completes last patient visit in ATH434-202 Phase 2 trial
Reuters·03/27 11:25
ALTERITY THERAPEUTICS LTD: TOPLINE DATA EXPECTED MID-YEAR 2025
TipRanks·03/27 10:28
Alterity Therapeutics Completes Key Phase 2 Trial for MSA Treatment
TipRanks·03/10 03:51
Alterity Therapeutics Reports Progress and Financial Results
TipRanks·02/19 12:17
Alterity Therapeutics Announces Change in Substantial Holding
TipRanks·02/18 13:27
Alterity Therapeutics Expands Capital with New Securities Quotation
TipRanks·02/18 13:17
Alterity Therapeutics Issues Over 1 Billion New Shares
Seeking Alpha·02/10 13:54
Alterity Therapeutics raises A$40 million
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.